We recently reported that patients with synchronous CRC metastases, harboring KRAS variants in primary tumors, had poor relapse-free survival, and this association was confirmed in the TCGA COAD-READ dataset [13], thus corroborating previous reports [44]. This evidence concerns the gene KRAS and colorectal carcinoma.